👉🏻 Stock name: Vimta Labs 👉🏻 breakout: Reverse head & shoulder pattern 👉🏻 50 & 200 EMA breakout 👉🏻 Volume: Higher
8 Day + Hourly Just above 300 ema apna, testing- Balaji (SUPER No Change Required + EMA ) 1) Consolidation 2) Looks good above Monhtly S R 3) May break soon and complete W
VIMTA Labs Above 450 Can do 480-500+ in short term. #Not a recommendation
Vimta labs has broken out after almost 2 years. Buy between 580-530 and EXIT if closes below 490
It has formed an uptrend pattern and after a pullback it has shown a breakout which is indicating that it is ready for a bullish movement. Buy at your own risk.
VIMTALABS - Short-term trade Expecting a good move Buy above 575 | Tgt 587, 600 and 620 | Sl 565 It is my view, to trade on your own analysis.
DON’T HAVE TIME TO MANAGE YOUR TRADES? - Take BTST trades at 3:25 pm every day - Try to exit by taking 4-7% profit of each trade - SL can also be maintained as closing below the low of the breakout candle Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and...
Weekly Breakout seen with LOW volume thus conviction in also low but one can give try by putting sl 485 for target of 550
vimta labs , heading towards 700,,accumulate near buying zone
good structure 700 next target. accumulate near buying zone.....the red line
Vimta lab has given squeezing Breakout today it may try to test red line
Entry - 415 Target - 475 SL - 397.5 Price retraced to EMA 10 & resuming Upmove EMA 10 > EMA 21 > EMA 50 > EMA 150 > EMA 200
Please look into the chart for a detailed understanding. Consider these for short-term & swing trades with 2% profit. For BTST trades consider booking target for 1% - 2% Please consider these ideas for educational purpose Comment below if you are looking for any answers.
Chart is self explanatory. Vimta Labs is one of the well known food testing companies in India. As per Management guidance, 1. Company is targeting 500 Cr Revenue for 2026; and 2. Margin Expansion upwards of 30% At expected Revenue of 500 Cr and EBIT margins of 32% by 2026 - EBIT will be around 160 Cr and Net Profit 80 Cr at current NPM of 15% This equates...
Look fresh in range 340-360 for upside 400-430 med term with SL 320..!!!
But at cmp 287 sl 275 cb Target 1 305 Target 2 320 Target 3 330 Closing above 330 can go for 360+ 400
Vimta Labs Analysis Fundamentals : Strong, Consistently increase in Sales, Profits and Reserves, DIIs, FIIs holding increasing. Technicals : Given Flag Pattern breakout forming triple bottom, C&H pattern formation, riding 52 weeks high! Target 1: 500 Target 2: 550 Target 3: 620 SL : 400
#VimyaLab had BO of IhnS at 330 level and now again a BO at 450 levels. Can be added for 34% upside from here for 610. CMP 461 Qtr Sales growth is flat but ROCE is healthy.